EP2616076 - Bibliographic data
COMPOSITIONS PHARMACEUTIQUES
| Last update | 11/07/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
VIIV HEALTHCARE COMPANY CSC
2711 Centerville Road
Suite 400
Wilmington, Delaware 19808
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Deepak B. MUNDHRA c/o GlaxoSmithKline
Global Patents Department
1250 South Collegeville Road
P. O. Box 5089
Collegeville, Pennsylvania 19426
États-Unis d'Amérique
Rennan PAN c/o GlaxoSmithKline
Global Patents Department
709 Swedeland Road
P. O. Box 1539
King of Prussia, Pennsylvania 19406
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient Cabinet José CURAU 17, rue Basse
98000
MONACO
Principauté de Monaco
|
| (21) Request number | EP11825920.9 |
|---|---|
| (22) Request date | 15/09/2011 |
| (11) Publication number | EP2616076 |
|---|---|
| Publication date | 13/07/2016 |
| (54) Title of the invention | COMPOSITIONS PHARMACEUTIQUES |
|---|---|
| (51) International classification | A61K 31/4985, A61P 31/18 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 383541 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity | Annuity: 15 - Amount: 390 € - Due date 30/09/2025 |
|---|---|
| Last annuity | Annuity: 14 - Payment date 23/08/2024 |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2016/42, of 21/10/2016 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 13/07/2016 Constitution de mandataire pour un dossier - Legal date 09/09/2016 |